Stoke Therapeutics (NASDAQ:STOK) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Stoke Therapeutics beat estimated earnings by 23.19%, reporting an EPS of $-0.53 versus an estimate of $-0.69.
Revenue was up $2.51 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 0.11% drop in the share price the next day.
Here’s a look at Stoke Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.70 | -0.68 | -0.71 | 0.36 |
| EPS Actual | -0.65 | -0.66 | -0.63 | -0.66 |
| Revenue Estimate | 2.58M | 2.45M | 2.35M | 40.00M |
| Revenue Actual | 3.27M | 2.90M | 3.23M | 3.00M |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Stoke Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
